Literature DB >> 25800464

[Tumor prostheses : Important in modern revision arthroplasty].

A Hillmann1, I Ipach.   

Abstract

BACKGROUND: Due to demographic aging, an increasing number of revision arthroplasty procedures is expected during upcoming years. While the use of a megaprosthesis for bone reconstruction after tumor resection is gold standard, this type of prosthesis still meets with reservation in the field of revision arthroplasty because of numerous risk factors.
OBJECTIVES: The purpose of this article is to present the importance of modular megaprostheses in revision arthroplasty, taking into consideration the risks of periprosthetic infection, aseptic loosening, material failure, and hip dislocation.
RESULTS: Because of improvements in the field of megaprostheses during the last 30 years, the risks after implantation of this type of prosthesis have significantly decreased. The risk of periprosthetic infection has been reduced about 1/3 by the use of silver surface coating. Improvements in stem design, cement technique, and the additional use of locking screws have minimized the risk of aseptic loosening. Improvements in material composition have reduced the risk of material failure. The risk of hip dislocation could also be minimized by careful tissue preparation and appropriate suture technique.
CONCLUSION: There is no need for the conservative use of megaprostheses in revision arthroplasty. There are many benefits in the use of megaprostheses in multimorbid patients (i.e., reduced operating time, the possibility of early full weight bearing, and a reduced risk of periprosthetic infection by the use of silver surface coating) instead of complex bone reconstruction during revision arthroplasty.

Entities:  

Mesh:

Year:  2015        PMID: 25800464     DOI: 10.1007/s00132-015-3086-z

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  15 in total

1.  Malignant tumor of the distal part of the femur or the proximal part of the tibia: endoprosthetic replacement or rotationplasty. Functional outcome and quality-of-life measurements.

Authors:  A Hillmann; C Hoffmann; G Gosheger; H Krakau; W Winkelmann
Journal:  J Bone Joint Surg Am       Date:  1999-04       Impact factor: 5.284

2.  Characteristics and outcome of infections associated with tumor endoprostheses.

Authors:  J Hardes; C Gebert; A Schwappach; H Ahrens; A Streitburger; W Winkelmann; G Gosheger
Journal:  Arch Orthop Trauma Surg       Date:  2006-04-21       Impact factor: 3.067

3.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

4.  Survival rates and causes of revision in cemented primary total knee replacement: a report from the Norwegian Arthroplasty Register 1994-2009.

Authors:  O Gøthesen; B Espehaug; L Havelin; G Petursson; S Lygre; P Ellison; G Hallan; O Furnes
Journal:  Bone Joint J       Date:  2013-05       Impact factor: 5.082

Review 5.  [Management of complications in megaprostheses].

Authors:  J Hardes; H Ahrens; G Gosheger; M Nottrott; R Dieckmann; M-P Henrichs; A Streitbürger
Journal:  Unfallchirurg       Date:  2014-07       Impact factor: 1.000

6.  Supracondylar distal femoral nonunions treated with a megaprosthesis in elderly patients: a report of two cases.

Authors:  J Davila; A Malkani; J M Paiso
Journal:  J Orthop Trauma       Date:  2001-11       Impact factor: 2.512

Review 7.  Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review.

Authors:  Eric R Henderson; John S Groundland; Elisa Pala; Jeremy A Dennis; Rebecca Wooten; David Cheong; Reinhard Windhager; Rainer I Kotz; Mario Mercuri; Philipp T Funovics; Francis J Hornicek; H Thomas Temple; Pietro Ruggieri; G Douglas Letson
Journal:  J Bone Joint Surg Am       Date:  2011-03-02       Impact factor: 5.284

8.  Distal femoral replacement in nontumor cases with severe bone loss and instability.

Authors:  Keith R Berend; Adolph V Lombardi
Journal:  Clin Orthop Relat Res       Date:  2008-06-04       Impact factor: 4.176

9.  Post operative infection and increased survival in osteosarcoma patients: are they associated?

Authors:  L M Jeys; R J Grimer; S R Carter; R M Tillman; A Abudu
Journal:  Ann Surg Oncol       Date:  2007-07-26       Impact factor: 5.344

10.  Countrywise results of total hip replacement. An analysis of 438,733 hips based on the Nordic Arthroplasty Register Association database.

Authors:  Keijo T Mäkelä; Markus Matilainen; Pekka Pulkkinen; Anne M Fenstad; Leif I Havelin; Lars Engesaeter; Ove Furnes; Søren Overgaard; Alma B Pedersen; Johan Kärrholm; Henrik Malchau; Göran Garellick; Jonas Ranstam; Antti Eskelinen
Journal:  Acta Orthop       Date:  2014-04       Impact factor: 3.717

View more
  1 in total

1.  Megaendoprostheses in the management of malignant tumors of the lower extremities-risk factors for revision surgery.

Authors:  Moritz von Salis-Soglio; Mohamed Ghanem; Christian Lycke; Andreas Roth; Georg Osterhoff
Journal:  J Orthop Surg Res       Date:  2021-08-18       Impact factor: 2.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.